1. Home
  2. YSS vs LGND Comparison

YSS vs LGND Comparison

Compare YSS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo York Space Systems Inc. Common Stock

YSS

York Space Systems Inc. Common Stock

N/A

Current Price

$17.06

Market Cap

2.4B

Sector

Industrials

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$300.53

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YSS
LGND
Founded
2012
1987
Country
United States
United States
Employees
710
68
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YSS
LGND
Price
$17.06
$300.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
7
Target Price
$36.56
$256.29
AVG Volume (30 Days)
1.1M
354.1K
Earning Date
03-19-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$48.43
$1.25
Revenue Next Year
$52.83
$19.41
P/E Ratio
N/A
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$16.93
$131.67
52 Week High
$44.54
$326.63

Technical Indicators

Market Signals
Indicator
YSS
LGND
Relative Strength Index (RSI) 31.61 54.03
Support Level N/A $290.20
Resistance Level $35.56 $326.63
Average True Range (ATR) 1.74 10.96
MACD -0.13 -3.74
Stochastic Oscillator 1.91 24.94

Price Performance

Historical Comparison
YSS
LGND

About YSS York Space Systems Inc. Common Stock

York Space Systems Inc is a U.S.-based space and defense company that provides mission-related solutions for national security, government, and commercial customers. The company develops its own hardware and software, offering capabilities intended to support customer requirements across various elements of the space mission lifecycle. It offers mission solutions across several complementary product categories: Components, Subsystems, Spacecraft Platforms, Ground Operation, Global Downlink, and Software-Enabled Services. The company derives the majority of revenue from long-term firm-fixed-price (FFP) production contracts for the design of small satellites, launch services, and ground services with both U.S. federal government-controlled agencies and domestic commercial customers.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: